Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1- and HIV-2-infected women in a community-based cohort in The Gambia

Journal of Acquired Immune Deficiency Syndromes

Volumn 38, Issue 3, 2005, Pages 335-341

  Hansmann, Andreas ^a,b   Van Der Loeff, Maarten F Schim ^a,c,f   Kaye, Steve ^a   Awasana, Akum Aveika ^a   Sarge Njie, Ramu ^a   O'Donovan, Diarmuid ^a,d   Ariyoshi, Koya ^a,e   Alabi, Abraham ^a   Milligan, Paul ^a   Whittle, Hilton C ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^f IATEC   (Netherlands)

Author keywords

Africa; CD4; HIV 1; HIV 2; Mortality; Natural history; Viral load; Women

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; FEMALE; FOLLOW UP; GAMBIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; SEROLOGY; SURVIVAL; T LYMPHOCYTE; VIRUS LOAD;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; GAMBIA; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; VIRAL LOAD;

EID: 20044385226     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. UNAIDS. Epidemic update. Available at: www.unaids.org/worldaidsday/2002/ press/update/epiupdate2002_en.doc. Accessed December 17, 2002.
2. Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 1994;265:1587-1590.
3. Kanki PJ, Travers KU, MBoup S, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet. 1994;343:943-946.
4. O'Donovan D, Ariyoshi K, Milligan P, et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. AIDS. 2000;14:441-448.
5. Schim van der Loeff MF, Jaffar S, Aveika AA, et al. Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia, West Africa. AIDS. 2002;16:1775-1783.
6. Collaborative Group on AIDS Incubation and HIV Survival. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet. 2000;255:1131-1137.
7. Morgan D, Muwonge R, Mahe C, et al. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialised countries? AIDS. 2002;16:597-603.
8. Crampin AC, Floyd S, Glynn JR, et al. Long-term follow-up of HIV-positive and HIV-negative individuals in rural Malawi. AIDS. 2002;16:1545-1550.
9. Ricard D, Wilkins A, NGum PT, et al. The effects of HIV-2 infection in a rural area of Guinea-Bissau. AIDS. 1994;8:977-982.
10. Poulsen AG, Aaby P, Larsen O, et al. 9-year HIV-2 associated mortality in an urban community in Bissau, West Africa. Lancet. 1997;349:911-914.
11. Norrgren H, da Silva ZJ, Andersson S, et al. Clinical features, immunological changes and mortality in a cohort of HIV-2 infected individuals in Bissau, Guinea-Bissau. Scand J Infect Dis. 1998;30:323-329.
12. Nunn AJ, Mulder DW, Kamali A, et al. Mortality associated with HIV-1 infection over five years in a rural Ugandan population: cohort study. BMJ. 1997;315:767-771.
13. Leroy V, Msellati P, Lepage P, et al. Four years of natural history of HIV-1 infection in African women: a prospective cohort study in Kigali (Rwanda), 1988-1993. J Acquir Immune Defic Syndr. 1995;9:415-421.
14. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167-1170.
15. Anastos K, Kalish LA, Hessol N, et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the Women's Interagency HIV Study. AIDS. 1999;13:1717-1726.
16. Katzenstein DA, Hammer SM, Hughes MD, et al. The relation of virological and immunological markers to clinical outcomes after nucleoside therapy in HIV infected adults with 200 to 500 CD4 cells per cubic millimeter. N Engl J Med. 1996;335:1091-1098.
17. O'Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. N Engl J Med. 1996;334:426-431.
18. O'Brien WA, Hartigan PM, Daar ES, et al. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. Ann Intern Med. 1997;126:939-945.
19. Ho DD. Viral counts in HIV infection. Science. 1996;272:1124-1125.
20. Berry N, Jaffar S, Schimn van der Loeff MF, et al. Low level viremia and high CD4% predict normal survival in a cohort of HIV-2 infected villagers. AIDS Res Hum Retroviruses. 2002;18:1167-1173.
21. Ota M, O'Donovan D, Alabi AS, et al. Maternal HIV-1 and HIV-2 infection and child survival in The Gambia. AIDS. 2000;14:435-439.
22. Ministry of Health, National AIDS Control Programme, The Gambia. Policies and Guidelines on HIV and AIDS. Banjul: Ministry of Health; 1995.
23. Boom R, Sol CJ, Salimans M, et al. Rapid and simple methods for purification of nucleic acids. J Clin Microbiol. 1990;28:495-503.
24. Berry N, Ariyoshi A, Shabbar J, et al. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J Hum Virol. 1998;1:457-468.
25. Ariyoshi K, Jaffar S, Alabi A, et al. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. AIDS. 2000;14:339-344.
26. Alabi AS, Jaffar S, Ariyoshi K, et al. Plasma viral load, CD4% and survival of HIV-1, HIV-2, and dually infected Gambian patients. AIDS. 2003;17:1513-1520.
27. Ryder RW, Batter VL, Nsuami M, et al. Fertility rates in 238 HIV-1 sero-positive women in Zaire followed for 3 years post-partum. AIDS. 1991;5: 1521-1527.
28. Gray RH, Wawer MJ, Serwadda D, et al. Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet. 1998;351:98-103.
29. Glynn JR, Buvé A, Caraël M, et al. Decreased fertility among HIV-1 infected women attending antenatal clinics in three African cities. JAIDS. 2000;25:345-352.
30. Boerma JT, Nunn AJ, Whitworth JA. Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries. AIDS. 1998;12(Suppl 1):S3-S14.
31. UNAIDS. Report on the global HIV/AIDS epidemic. Geneva: UNAIDS; 2002.
32. Berry N, Ariyoshi K, Balfe P, et al. Sequence specificity of the human immunodeficiency virus type 2 (HIV-2) long terminal repeat u3 region in vivo allows subtyping of the principal HIV-2 viral subtypes A and B. AIDS Res Hum Retroviruses. 2001;17:263-267.
33. Grassly NC, Xiang Z, Ariyoshi K, et al. Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype. J Virol. 1998;72:7895-7899.
34. Kilmarx PH. Commentary: virus, host, or environment? BMJ. 2002;324:197.
35. Morgan D, Mahe C, Mayanja B, et al. Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. BMJ. 2002;324:193-196.
36. van der Ende ME, Schutten M, Ly TD, et al. HIV-2 infection in 12 European residents: virus characteristics and disease progression. AIDS. 1996;10:1649-1655.
37. Smith NA, Shaw T, Berry N, et al. Antiretroviral therapy for HIV-2 infected patients. J Infect. 2001;42:126-133.
38. Cox S, Aperia K, Albert J, et al. Comparison of the sensitivities of primary isolates of HIV type 2 and HIV type 1 to antiretroviral drugs and drug combinations. AIDS Res Hum Retroviruses. 1994;12:1725-1728.
39. Witvrouw M, Pannecouque C, Laethem KV, et al. Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV. AIDS. 1999;13:1477-1483.